Müller-Tidow C - Search Results

1

Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia.

Ottmann OG, Müller-Tidow C, Krämer A, Schlenk RF, Lübbert M, Bug G, Krug U, Bochtler T, Voss F, Taube T, Liu D, Garin-Chesa P, Döhner H. Ottmann OG, et al. Br J Haematol. 2019 Mar;184(6):1018-1021. doi: 10.1111/bjh.15204. Epub 2018 Jun 8. Br J Haematol. 2019. PMID: 29882583 Free article. Clinical Trial. No abstract available.

2

Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia.

Tiesmeier J, Czwalinna A, Müller-Tidow C, Krauter J, Serve H, Heil G, Ganser A, Verbeek W. Tiesmeier J, et al. Br J Haematol. 2003 Nov;123(3):413-9. doi: 10.1046/j.1365-2141.2003.04618.x. Br J Haematol. 2003. PMID: 14616999 Free article.

3

Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation.

Koschmieder S, Agrawal S, Radomska HS, Huettner CS, Tenen DG, Ottmann OG, Berdel WE, Serve HL, Müller-Tidow C. Koschmieder S, et al. Int J Oncol. 2007 Feb;30(2):349-55. Int J Oncol. 2007. PMID: 17203216

4

New molecular therapy targets in acute myeloid leukemia.

Krug U, Serve H, Müller-Tidow C, Mesters RM, Steffen B, Büchner T, Berdel WE. Krug U, et al. Recent Results Cancer Res. 2007;176:243-62. doi: 10.1007/978-3-540-46091-6_21. Recent Results Cancer Res. 2007. PMID: 17607931 Review.

5

Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.

Kessler T, Mohr M, Müller-Tidow C, Krug U, Brunnberg U, Mohr B, Schliemann C, Sauerland C, Serve H, Büchner T, Berdel WE, Mesters RM. Kessler T, et al. Leuk Res. 2008 Mar;32(3):491-4. doi: 10.1016/j.leukres.2007.06.015. Epub 2007 Aug 1. Leuk Res. 2008. PMID: 17675230 Clinical Trial.

6

Identification of acute myeloid leukaemia associated microRNA expression patterns.

Isken F, Steffen B, Merk S, Dugas M, Markus B, Tidow N, Zühlsdorf M, Illmer T, Thiede C, Berdel WE, Serve H, Müller-Tidow C. Isken F, et al. Br J Haematol. 2008 Jan;140(2):153-61. doi: 10.1111/j.1365-2141.2007.06915.x. Br J Haematol. 2008. PMID: 18173753 Free article.

7

Advances in the treatment of acute myeloid leukemia: from chromosomal aberrations to biologically targeted therapy.

Lübbert M, Müller-Tidow C, Hofmann WK, Koeffler HP. Lübbert M, et al. J Cell Biochem. 2008 Aug 15;104(6):2059-70. doi: 10.1002/jcb.21770. J Cell Biochem. 2008. PMID: 18613031 Review.

8

Splenic marginal zone lymphoma: transformation to diffuse large B-cell lymphoma with isolated cerebral manifestation.

Thoennissen NH, Keyvani K, Voelker HU, Bremer J, Krug U, Müller-Tidow C, Koch P, Müller-Hermelink HK, Berdel WE. Thoennissen NH, et al. J Clin Oncol. 2008 Sep 20;26(27):4509-11. doi: 10.1200/JCO.2008.17.6172. J Clin Oncol. 2008. PMID: 18802164 No abstract available.

9

Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells.

Krug U, Yasmeen A, Beger C, Bäumer N, Dugas M, Berdel WE, Müller-Tidow C. Krug U, et al. Int J Oncol. 2009 Jan;34(1):129-36. Int J Oncol. 2009. PMID: 19082485

10

S100A2 induces metastasis in non-small cell lung cancer.

Bulk E, Sargin B, Krug U, Hascher A, Jun Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, Hotfilder M, Marra A, Koschmieder S, Dugas M, Berdel WE, Serve H, Müller-Tidow C. Bulk E, et al. Clin Cancer Res. 2009 Jan 1;15(1):22-9. doi: 10.1158/1078-0432.CCR-08-0953. Clin Cancer Res. 2009. PMID: 19118029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

506 results

Search Page